Trio Healthcare has upgraded its production lines with a multimillion pound funding package from HSBC UK to boost its international growth.

Yorkshire healthcare solutions firm upgrades equipment with multimillion pound HSBC backing

A Yorkshire healthcare solutions manufacturer has upgraded its production lines with a multimillion pound funding package from HSBC UK to boost its international growth.

Trio Healthcare, based in Skipton and owned by Impel Healthcare Catalysts in, has used part of the funding to purchase a UK-made novel production line incorporating the company’s patent-protected processes.

The company said that the new equipment is “crucial” for its plan to commercialise and manufacture a new ostomy product for the worldwide market.

The product, which will be launched to the market this year, aims to allow ostomy patients, such as those with Crohn’s disease and ulcerative colitis, to lead more comfortable lives.

Trio Healthcare expects to see the business create highly skilled jobs at its Skipton site and increase turnover significantly over the next couple of years.

Richard Anderson, co-founder of Impel Healthcare Catalysts, commented: “We have a long-standing relationship with HSBC UK from our time running Crawford Healthcare.

“We always found the bank bought-into everything we sought to achieve and was highly supportive of us as a management team.

“As a result, I was delighted to offer it the opportunity to work with us again at Trio and I believe its involvement endorses what we are seeking to achieve with the business.”

Lloyd Pearce, founder and CEO of Trio, said: “The investment and partnership with Impel in 2019 was the most important event in Trio’s history since I founded the business in 2006.

“I am genuinely excited by the future and the difference we are making to the lives of ostomates, and thrilled to have HSBC UK with us for the journey.”

David Edwards, corporate relationship director atHSBC UK, added: “Trio Healthcare is a truly global Yorkshire enterprise and it is no exaggeration to say that its radically disruptive product will improve the lives of millions around the world.

“Since its launch 14 years ago, the business has invested heavily into R&D [research and development] and manufacturing capability, with this new machine being the accumulation of years of work.”

Our Partners